Literature DB >> 32501536

Which are the "emergent" dermatologic practices during COVID-19 pandemic? Report from the lockdown in Milan, Italy.

Serena Giacalone1, Paolo Bortoluzzi1, Gianluca Nazzaro2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32501536      PMCID: PMC7300752          DOI: 10.1111/ijd.15005

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


× No keyword cloud information.
Dear Editor, In March 2020, Kwatra launched an international warning about the risk of dermatological practices as vectors for COVID‐19 transmission, emphasizing the necessity of an immediate cessation of nonemergent visits. Since March 9, only urgent and deferred consultations, i.e. with a 3‐day and 10‐day priority, respectively, were admitted in our Dermatology Unit, upon first evaluation of the general practitioner. During the period corresponding to Italian lockdown, from March 9 to May 4, 203 “priority” patients were admitted (105 males, 98 females) with a median age of 49 years. Pediatric dermatological consultations were carried out in a separated department to avoid overcrowding. Patients' characteristics and their diagnoses are shown in Table 1.
Table 1

Patients' characteristics and diagnoses during Italian lockdown (Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)

DiagnosisNo of patients <65 years oldNo of patients >65 years oldTotal
Eczema of any causes342054
Seborrheic dermatitis303
Hand eczema16824
Psoriasis11516
Prurigo246
Repetitive self‐harm syndrome101
Urticaria7411
Pressure urticaria101
Acne303
Rosacea224
Total inflammatory diseases603595
Melanoma213
Nonmelanoma skin cancer156
Benign neoplasms251540
Total skin neoplasms282149
Scabies11415
Herpes zoster336
Herpes simplex404
Wart202
Molluscum contagiosum202
Body lice infestation112
Folliculitis and furunculosis437
Cutaneous abscess314
Dermatophytosis022
Total infectious diseases301444
Pityriasis rosea404
Leg purpura033
Maculopapular exanthema101
Total parainfective rash538
Blistering diseases123
Scleroderma123
Annular granuloma011
Total immunopathology257
Total12578203
Patients' characteristics and diagnoses during Italian lockdown (Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico) The most common diagnosis was dermatitis of any causes (54/203; 26.6%): in particular, 24 patients (11.8%) were diagnosed for hand eczema while 30 (14.8%) presented with diffuse eczema, seborrheic, and atopic dermatitis. The second most common group of diseases were the infectious ones (44/203, 21.7%): scabies (15/203, 7.4%) and herpes zoster (6/203, 3%) were the most frequent. Sixteen patients (7.9%) received a diagnosis of psoriasis, in mild‐severe form, being eligible for systemic therapy. Eleven patients (5.4%) had a diagnosis of acute urticaria, among which a patient, who was a nurse at work, was classified as pressure urticaria related to the use of a filter facial mask. Other diagnoses were prurigo (6 patients, 3%), acne (3 patients, 1.5%), and rosacea (4, 2%), while nine patients (4.4%) had a diagnosis of cutaneous malignancy: three melanomas and six nonmelanoma skin cancers. Finally, we observed eight parainfective rash (3.9%): four with the features of pityriasis rosea, three presenting as purpura of the legs, and one maculopapular exanthema. These dermatological manifestations were also described in association with COVID‐19 infection: three of eight patients reported previous symptoms as asthenia and fever, but none of them had undergone nasopharyngeal swab. In the lockdown period, we recorded a reduction in more than half of the urgent dermatological consultations, if compared with 419 in the same period of the last year. We also noted a reduction in the mean age of the patients, reflecting the lower concern for contagion of young patients. The most frequent diagnosis was hand dermatitis; there was often an association with repetitive or obsessive hand washing, abuse of sanitizing gel, and improper use of gloves. Although Yan et al reported an increased number of facial dermatoses (acne, rosacea, seborrheic dermatitis) among healthcare workers due to the use of facial masks, we did not observe an increase in general population. This is related to the different type of masks, usually surgical mask or homemade mask, with less filtering capacity and less adherence on the face. However, considering the new rules of phase 2 that allow visiting relatives and return to work wearing a mask mandatory, we expect an increase also of these diseases because of the occlusive effect of the masks. Eventually, we want to share some considerations about the clinical practice during lockdown. The use of personal protective equipment and social distancing may affect quality and length of visiting: patients tend to show the affected part of body, goggles and other facial protections can interfere with dermoscopy; elderly patients, with hearing difficulties, struggle to understand the prescription as they do not see the lable. Moreover, both doctors and patients are reluctant to perform inspections of the oral cavity and/or evaluation of facial lesions. On May 4, the Italian Government moved on phase 2 of pandemic crisis, easing some restrictions in people's daily activities. Our Dermatologic Department is also experiencing a gradual return to normal activities.
  3 in total

1.  What is the role of a dermatologist in the battle against COVID-19? The experience from a hospital on the frontline in Milan.

Authors:  Gianluca Nazzaro; Angelo V Marzano; Emilio Berti
Journal:  Int J Dermatol       Date:  2020-05-07       Impact factor: 2.736

2.  Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019.

Authors:  Yicen Yan; Hui Chen; Liuqing Chen; Bo Cheng; Ping Diao; Liyun Dong; Xinghua Gao; Heng Gu; Li He; Chao Ji; Hongzhong Jin; Wei Lai; Tiechi Lei; Li Li; Liuyi Li; Ruoyu Li; Dongxian Liu; Wei Liu; Qianjin Lu; Ying Shi; Jiquan Song; Juan Tao; Baoxi Wang; Gang Wang; Yan Wu; Leihong Xiang; Jun Xie; Jinhua Xu; Zhirong Yao; Furen Zhang; Jianzhong Zhang; Shaomin Zhong; Hengjin Li; Hang Li
Journal:  Dermatol Ther       Date:  2020-03-29       Impact factor: 2.851

3.  Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits.

Authors:  Shawn G Kwatra; Ronald J Sweren; Anna L Grossberg
Journal:  J Am Acad Dermatol       Date:  2020-03-22       Impact factor: 15.487

  3 in total
  5 in total

Review 1.  The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.

Authors:  Gianmarco Lugli; Matteo Maria Ottaviani; Annarita Botta; Guido Ascione; Alessandro Bruschi; Federico Cagnazzo; Lorenzo Zammarchi; Paola Romagnani; Tommaso Portaluri
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-01-01       Impact factor: 2.576

2.  The effect of the COVID-19 pandemic on dermatology consultation requests from adult and paediatric emergency departments.

Authors:  Neslihan Demirel Öğüt; Gülsün Hazan Tabak; Duygu Gülseren; Başak Yalıcı-Armağan; Neslihan Akdoğan; Sibel Doğan; Gonca Elçin; Ayşen Karaduman; Sibel Ersoy Evans
Journal:  Int J Clin Pract       Date:  2021-09-27       Impact factor: 3.149

3.  The course of acne in healthcare workers during the COVID-19 pandemic and evaluation of possible risk factors.

Authors:  Birgül Özkesici Kurt
Journal:  J Cosmet Dermatol       Date:  2021-10-12       Impact factor: 2.696

4.  Emergency accesses in Dermatology Department during the Covid-19 pandemic in a referral third level center in the north of Italy.

Authors:  Eugenio Isoletta; Camilla Vassallo; Valeria Brazzelli; Chiara Giorgini; Carlo Francesco Tomasini; Anna Sabena; Stefano Perlini; Annalisa De Silvestri; Stefania Barruscotti
Journal:  Dermatol Ther       Date:  2020-09-02       Impact factor: 3.858

5.  Facial dermatoses in the general population due to wearing of personal protective masks during the COVID-19 pandemic: first observations after lockdown.

Authors:  S Giacalone; A Minuti; C B Spigariolo; E Passoni; G Nazzaro
Journal:  Clin Exp Dermatol       Date:  2020-08-26       Impact factor: 4.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.